Daniela Matei

  • 6985 Citations
  • 41 h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1995 2019

Filter
Article
2014
67 Citations (Scopus)

TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells

Cardenas, H., Vieth, E., Lee, J., Segar, M., Liu, Y., Nephew, K. & Matei, D., Dec 18 2014, In : Epigenetics : official journal of the DNA Methylation Society. 9, 11, p. 1461-1472 12 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
DNA Methylation
Ovarian Neoplasms
Methylation
Epigenomics
55 Citations (Scopus)

The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer

Fang, F., Munck, J., Tang, J., Taverna, P., Wang, Y., Miller, D. F. B., Pilrose, J., Choy, G., Azab, M., Pawelczak, K. S., VanderVere-Carozza, P., Wagner, M., Lyons, J., Matei, D., Turchi, J. & Nephew, K., Dec 15 2014, In : Clinical Cancer Research. 20, 24, p. 6504-6516 13 p.

Research output: Contribution to journalArticle

DNA Methylation
Ovarian Neoplasms
Cisplatin
Platinum
Tumor Suppressor Genes
2013
28 Citations (Scopus)

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

Matulonis, U. A., Lee, J., Lasonde, B., Tew, W. P., Yehwalashet, A., Matei, D., Behbakht, K., Grothusen, J., Fleming, G., Lee, N. K., Arnott, J., Bray, M. R., Fletcher, G., Brokx, R. D., Castonguay, V., MacKay, H., Sidor, C. F. & Oza, A. M., Jan 2013, In : European Journal of Cancer. 49, 1, p. 121-131 11 p.

Research output: Contribution to journalArticle

Angiogenesis Inhibitors
Platinum
Ovarian Neoplasms
Phosphotransferases
Mitotic Index
35 Citations (Scopus)

Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer

Yakubov, B., Chelladurai, B., Schmitt, J., Emerson, R., Turchi, J. & Matei, D., 2013, In : Neoplasia. 15, 6, p. 609-619 11 p.

Research output: Contribution to journalArticle

NF-kappa B
Ovarian Neoplasms
Neoplasm Metastasis
CD44 Antigens
Proteins
7 Citations (Scopus)

Live tissue viability and chemosensitivity assays using digital holographic motility contrast imaging

An, R., Turek, J., Matei, D. & Nolte, D., Jan 1 2013, In : Applied Optics. 52, 1

Research output: Contribution to journalArticle

locomotion
viability
Assays
Tissue
Imaging techniques
76 Citations (Scopus)

Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial

Colombo, N., McMeekin, D. S., Schwartz, P. E., Sessa, C., Gehrig, P. A., Holloway, R., Braly, P., Matei, D., Morosky, A., Dodion, P. F., Einstein, M. H. & Haluska, F., Mar 19 2013, In : British Journal of Cancer. 108, 5, p. 1021-1026 6 p.

Research output: Contribution to journalArticle

Endometrial Neoplasms
Sirolimus
ridaforolimus
Hyperglycemia
Disease-Free Survival
26 Citations (Scopus)

Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism

Condello, S., Cao, L. & Matei, D., Aug 2013, In : FASEB Journal. 27, 8, p. 3100-3112 13 p.

Research output: Contribution to journalArticle

Catenins
Ovarian Neoplasms
Cadherins
Fibronectins
Cell adhesion
15 Citations (Scopus)
Germ Cell and Embryonal Neoplasms
Pediatrics
Research
Oncologists
2012
217 Citations (Scopus)

Epigenetic resensitization to platinum in ovarian cancer

Matei, D., Fang, F., Shen, C., Schilder, J., Arnold, A., Zeng, Y., Berry, W. A., Huang, T. & Nephew, K., May 1 2012, In : Cancer Research. 72, 9, p. 2197-2205 9 p.

Research output: Contribution to journalArticle

decitabine
Platinum
Epigenomics
Ovarian Neoplasms
Disease-Free Survival
122 Citations (Scopus)

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients

Alley, W. R., Vasseur, J. A., Goetz, J. A., Svoboda, M., Mann, B. F., Matei, D. E., Menning, N., Hussein, A., Mechref, Y. & Novotny, M. V., Apr 6 2012, In : Journal of Proteome Research. 11, 4, p. 2282-2300 19 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Polysaccharides
Blood
Serum
Immunoglobulin G
878 Citations (Scopus)

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Macpherson, E., Watkins, C., Carmichael, J. & Matulonis, U., Apr 12 2012, In : New England Journal of Medicine. 366, 15, p. 1382-1392 11 p.

Research output: Contribution to journalArticle

Platinum
Ovarian Neoplasms
Placebos
Disease-Free Survival
Therapeutics
37 Citations (Scopus)

Targeting angiogenesis in ovarian cancer

Schmitt, J. & Matei, D., Jun 2012, In : Cancer Treatment Reviews. 38, 4, p. 272-283 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Angiopoietins
Critical Pathways
Tumor Microenvironment
Fibroblast Growth Factors
24 Citations (Scopus)

Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer

Shao, M., Hollar, S., Chambliss, D., Schmitt, J., Emerson, R., Chelladurai, B., Perkins, S., Ivan, M. & Matei, D., Jul 2012, In : Molecular Cancer Therapeutics. 11, 7, p. 1576-1586 11 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Vascular Endothelial Growth Factor A
Intercellular Signaling Peptides and Proteins
Insulin
Heterografts
122 Citations (Scopus)

Tissue transglutaminase links TGF-Β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer

Cao, L., Shao, M., Schilder, J., Guise, T., Mohammad, K. & Matei, D., May 17 2012, In : Oncogene. 31, 20, p. 2521-2534 14 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Transforming Growth Factors
Ovarian Neoplasms
Stem Cells
Phenotype
2011
137 Citations (Scopus)

Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A Gynecologic Oncology Group trial

Matei, D., Sill, M. W., Lankes, H. A., DeGeest, K., Bristow, R. E., Mutch, D., Yamada, S. D., Cohn, D., Calvert, V., Farley, J., Petricoin, E. F. & Birrer, M. J., Jan 1 2011, In : Journal of Clinical Oncology. 29, 1, p. 69-75 7 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Carcinoma
Disease-Free Survival
Neoplasms
raf Kinases
29 Citations (Scopus)

PDGF induced microRNA alterations in cancer cells

Shao, M., Rossi, S., Chelladurai, B., Shimizu, M., Ntukogu, O., Ivan, M., Calin, G. A. & Matei, D., May 2011, In : Nucleic Acids Research. 39, 10, p. 4035-4047 13 p.

Research output: Contribution to journalArticle

Platelet-Derived Growth Factor
MicroRNAs
Neoplasms
Glioblastoma
Epidermal Growth Factor Receptor
44 Citations (Scopus)

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

Ramasubbaiah, R., Perkins, S., Schilder, J., Whalen, C., Johnson, C. S., Callahan, M., Jones, T., Sutton, G. & Matei, D., Dec 2011, In : Gynecologic Oncology. 123, 3, p. 499-504 6 p.

Research output: Contribution to journalArticle

Topotecan
Ovarian Neoplasms
Platinum
Carcinoma
Hand-Foot Syndrome
24 Citations (Scopus)

Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase

Khanna, M., Chelladurai, B., Gavini, A., Li, L., Shao, M., Courtney, D., Turchi, J., Matei, D. & Meroueh, S., Apr 2011, In : Molecular Cancer Therapeutics. 10, 4, p. 626-636 11 p.

Research output: Contribution to journalArticle

Fibronectins
Cell Adhesion
Neoplasms
Cell-Matrix Junctions
Peptidyl Transferases
2010
102 Citations (Scopus)

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

Fang, F., Balch, C., Schilder, J., Breen, T., Zhang, S., Shen, C., Li, L., Kulesavage, C., Snyder, A. J., Nephew, K. & Matei, D., Sep 1 2010, In : Cancer. 116, 17, p. 4043-4053 11 p.

Research output: Contribution to journalArticle

decitabine
Carboplatin
Platinum
Ovarian Neoplasms
DNA Methylation
4 Citations (Scopus)

Blockade of FGF signaling: Therapeutic promise for ovarian cancer

Ivan, M. & Matei, D., Sep 1 2010, In : Cancer Biology and Therapy. 10, 5, p. 505-508 4 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
Fibroblast Growth Factors
Alternative Splicing
Antineoplastic Agents
Ovarian Neoplasms
16 Citations (Scopus)

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer

Hess, L. M., Rong, N., Monahan, P., Gupta, P., Thomaskutty, C. & Matei, D., Nov 15 2010, In : Cancer. 116, 22, p. 5251-5260 10 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Drug Therapy
Survival
Therapeutics
Meta-Analysis
72 Citations (Scopus)

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer

Matei, D. & Nephew, K., Feb 2010, In : Gynecologic Oncology. 116, 2, p. 195-201 7 p.

Research output: Contribution to journalArticle

Epigenomics
Ovarian Neoplasms
decitabine
Pharmaceutical Preparations
DNA Methylation
53 Citations (Scopus)

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

De Geest, K., Blessing, J. A., Morris, R. T., Yamada, S. D., Monk, B. J., Zweizig, S. L., Matei, D., Muller, C. Y. & Richards, W. E., Jan 1 2010, In : Journal of Clinical Oncology. 28, 1, p. 149-153 5 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Platinum
Neoplasms
Carcinoma
Mucositis
32 Citations (Scopus)

Role of epigenomics in ovarian and endometrial cancers

Balch, C., Matei, D., Huang, T. H. M. & Nephew, K., Jun 2010, In : Epigenomics. 2, 3, p. 419-447 29 p.

Research output: Contribution to journalArticle

Endometrial Neoplasms
Epigenomics
Ovarian Neoplasms
Neoplasms
Histone Code
2009
68 Citations (Scopus)
Platinum
Ovarian Neoplasms
Nanoparticles
Carcinoma
2-methoxyestradiol
2 Citations (Scopus)

Breast mass in a patient with ovarian cancer: A case report

Gayathri, S., Badve, S. & Matei, D., Oct 2009, In : Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 54, 10, p. 639-644 6 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Breast
Carcinoma
Neoplasm Metastasis
Neoplasms
32 Citations (Scopus)

Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: A gynecologic oncology group study

Matei, D., Miller, A. M., Monahan, P., Gershenson, D., Zhao, Q., Cella, D., Champion, V. & Williams, S. D., Sep 1 2009, In : Journal of Clinical Oncology. 27, 25, p. 4142-4149 8 p.

Research output: Contribution to journalArticle

Patient Acceptance of Health Care
Germ Cell and Embryonal Neoplasms
Survivors
Nausea
Hypesthesia
89 Citations (Scopus)

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase

Shao, M., Cao, L., Shen, C., Satpathy, M., Chelladurai, B., Bigsby, R., Nakshatri, H. & Matei, D., Dec 15 2009, In : Cancer Research. 69, 24, p. 9192-9201 10 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Ovarian Neoplasms
Neoplasms
Neoplasm Metastasis
Heterografts
106 Citations (Scopus)

Minireview: Epigenetic changes in ovarian cancer

Balch, C., Fang, F., Matei, D., Huang, T. H. M. & Nephew, K., Sep 2009, In : Endocrinology. 150, 9, p. 4003-4011 9 p.

Research output: Contribution to journalArticle

Epigenomics
Ovarian Neoplasms
DNA Methylation
Neoplasms
Histone Code

Minireview: Epigenetic changes in ovarian cancer

Balch, C., Fang, F., Matei, D., Huang, T. H. M. & Nephew, K., 2009, In : Journal of Clinical Endocrinology and Metabolism. 94, 9, p. 3617 1 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)

Pegylated liposomal doxorubicin in ovarian cancer

Strother, R. & Matei, D., 2009, In : Therapeutics and Clinical Risk Management. 5, 1, p. 639-650 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Toxicity
cancer
Doxorubicin
Carboplatin
85 Citations (Scopus)

Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

Vergote, I., Finkler, N., del Campo, J., Lohr, A., Hunter, J., Matei, D., Kavanagh, J., Vermorken, J. B., Meng, L., Jones, M., Brown, G. & Kaye, S., Sep 2009, In : European Journal of Cancer. 45, 13, p. 2324-2332 9 p.

Research output: Contribution to journalArticle

Topotecan
Platinum
Ovarian Neoplasms
Disease-Free Survival
Survival
49 Citations (Scopus)

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity

Satpathy, M., Shao, M., Emerson, R., Donner, D. B. & Matei, D., Jun 5 2009, In : Journal of Biological Chemistry. 284, 23, p. 15390-15399 10 p.

Research output: Contribution to journalArticle

Cyclic AMP Response Element-Binding Protein
Matrix Metalloproteinase 2
Ovarian Neoplasms
transglutaminase 2
Transcription
2008
31 Citations (Scopus)

A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma

Kimball, K. J., Numnum, T. M., Kirby, T. O., Zamboni, W. C., Estes, J. M., Barnes, M. N., Matei, D., Koch, K. M. & Alvarez, R. D., Oct 2008, In : Gynecologic Oncology. 111, 1, p. 95-101 7 p.

Research output: Contribution to journalArticle

Carboplatin
Platinum
Carcinoma
Pharmacokinetics
Neutropenia
856 Citations (Scopus)

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Zhang, S., Balch, C., Chan, M. W., Lai, H. C., Matei, D., Schilder, J., Yan, P. S., Huang, T. H. M. & Nephew, K., Jun 1 2008, In : Cancer Research. 68, 11, p. 4311-4320 10 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Neoplasms
Stem Cells
Adenocarcinoma
Up-Regulation
57 Citations (Scopus)

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial

Matei, D., Emerson, R., Schilder, J., Menning, N., Baldridge, L. A., Johnson, C. S., Breen, T., McClean, J., Stephens, D., Whalen, C. & Sutton, G., Aug 15 2008, In : Cancer. 113, 4, p. 723-732 10 p.

Research output: Contribution to journalArticle

docetaxel
Platinum
Ovarian Neoplasms
Platelet-Derived Growth Factor Receptors
Carcinoma
7 Citations (Scopus)

Platelet-derived growth factor pathway inhibitors in ovarian cancer

Schmitt, J. & Matei, D., Dec 2008, In : Clinical Ovarian Cancer. 1, 2, p. 120-126 7 p.

Research output: Contribution to journalArticle

Platelet-Derived Growth Factor Receptors
Platelet-Derived Growth Factor
Ovarian Neoplasms
Neoplasms
Pericytes
74 Citations (Scopus)
Cisplatin
Cell Survival
NF-kappa B
Apoptosis
Ovarian Neoplasms
2007
79 Citations (Scopus)

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase

Satpathy, M., Cao, L., Pincheira, R., Emerson, R., Bigsby, R., Nakshatri, H. & Matei, D., Aug 1 2007, In : Cancer Research. 67, 15, p. 7194-7202 9 p.

Research output: Contribution to journalArticle

Neoplasms
Fibronectins
Cell Adhesion
Integrins
Phenotype
13 Citations (Scopus)

Novel agents in ovarian cancer

Matei, D., Aug 2007, In : Expert Opinion on Investigational Drugs. 16, 8, p. 1227-1239 13 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Biological Phenomena
Therapeutics
Drug Therapy
Neoplasms
47 Citations (Scopus)

PDGF BB induces VEGF secretion in ovarian cancer

Matei, D., Kelich, S., Cao, L., Menning, N., Emerson, R., Rao, J., Meei, H. J. & Sledge, G. W., Dec 2007, In : Cancer Biology and Therapy. 6, 12, p. 1951-1959 9 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Vascular Endothelial Growth Factor A
Platelet-Derived Growth Factor Receptors
Ascites
Neoplasms
54 Citations (Scopus)

The platelet-derived growth factor receptor α is destabilized by geldanamycins in cancer cells

Matei, D., Satpathy, M., Cao, L., Lai, Y. C., Nakshatri, H. & Donner, D. B., Jan 5 2007, In : Journal of Biological Chemistry. 282, 1, p. 445-453 9 p.

Research output: Contribution to journalArticle

tanespimycin
Platelet-Derived Growth Factor Receptors
Cells
Neoplasms
Neutralizing Antibodies
2006
97 Citations (Scopus)

Autocrine activation of PDGFRα promotes the progression of ovarian cancer

Matei, D., Emerson, R., Lai, Y. C., Baldridge, L. A., Rao, J., Yiannoutsos, C. & Donner, D. B., Mar 30 2006, In : Oncogene. 25, 14, p. 2060-2069 10 p.

Research output: Contribution to journalArticle

Platelet-Derived Growth Factor Receptors
Ovarian Neoplasms
Ligands
Ascitic Fluid
Conditioned Culture Medium
202 Citations (Scopus)

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: Potential predictive relationship with tumor HER2 activation status

Gordon, M. S., Matei, D., Aghajanian, C., Matulonis, U. A., Brewer, M., Fleming, G. F., Hainsworth, J. D., Garcia, A. A., Pegram, M. D., Schilder, R. J., Cohn, D. E., Roman, L., Derynck, M. K., Ng, K., Lyons, B., Allison, D. E., Eberhard, D. A., Pham, T. Q., Dere, R. C. & Karlan, B. Y., Sep 10 2006, In : Journal of Clinical Oncology. 24, 26, p. 4324-4332 9 p.

Research output: Contribution to journalArticle

Dimerization
Ovarian Neoplasms
Neoplasms
Disease-Free Survival
pertuzumab

Neuroprotective effects of vitamin E

Matei, D., Mar 2006, In : Women's Oncology Review. 6, 1-2, p. 97-98 2 p.

Research output: Contribution to journalArticle

Neuroprotective Agents
Vitamin E
2005
53 Citations (Scopus)

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer

Chan, M. W. Y., Wei, S. H., Wen, P., Wang, Z., Matei, D., Liu, J. C., Liyanarachchi, S., Brown, R., Nephew, K., Yan, P. S. & Huang, T. H. M., Oct 15 2005, In : Clinical Cancer Research. 11, 20, p. 7376-7383 8 p.

Research output: Contribution to journalArticle

Ribosomal DNA
Ovarian Neoplasms
Disease-Free Survival
Methylation
DNA Methylation
2004
93 Citations (Scopus)
Platelet-Derived Growth Factor Receptors
Ovarian Neoplasms
Growth
Imatinib Mesylate
Cell Proliferation

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study

Fleming, G. F., Brunetto, V. L., Cella, D., Look, K. Y., Reid, G. C., Munkarah, A. R., Kline, R., Burger, R. A., Goodman, A. K., Burks, R. T. & Matei, D., Dec 2004, In : Women's Oncology Review. 4, 4, p. 287-289 3 p.

Research output: Contribution to journalArticle

Endometrial Neoplasms
Paclitaxel
Doxorubicin
Cisplatin
Filgrastim
2002
82 Citations (Scopus)

Gene expression in epithelial ovarian carcinoma

Matei, D., Graeber, T. G., Baldwin, R. L., Karlan, B. Y., Rao, J. & Chang, D. D., Sep 12 2002, In : Oncogene. 21, 41, p. 6289-6298 10 p.

Research output: Contribution to journalArticle

Epithelial Cells
Carcinoma
Gene Expression
Ovary
Cultured Cells
413 Citations (Scopus)

Periostin secreted by epithelial ovarian carcinoma is a ligand for αVβ3 and αVβ5 integrins and promotes cell motility

Gillan, L., Matei, D., Fishman, D. A., Gerbin, C. S., Karlan, B. Y. & Chang, D. D., Sep 15 2002, In : Cancer Research. 62, 18, p. 5358-5364 7 p.

Research output: Contribution to journalArticle

Integrins
Cell Movement
Ligands
Carcinoma
Ovarian Neoplasms